Reports of Scientific Meetings

The AACR’s cutting-edge scientific meetings and high-impact journals work in concert to support the Association’s mission of fostering the prevention and cure of cancer through research, education, communication, and collaboration. The journals of the AACR offer a vital forum for important scientific meetings conducted by the Association and by other scientific societies.

AACR journals routinely publish peer-reviewed Meeting Reports written by high-profile scientists. In addition, the journals occasionally publish Supplement issues containing the proceedings of important meetings in full-length peer-reviewed articles.

Full-text HTML and PDF versions are available for all meeting reports listed below.

Reports of AACR Meetings

Meetings Held in 2007

In the Forefront of Basic and Translational Cancer Research: Seventh Joint Conference of the American Association for Cancer Research and the Japanese Cancer Association

Waikoloa, HI, on January 21 to 25, 2007
Meeting Report: Cancer Research 2007
DOI: 10.1158/0008-5472.CAN-07-1102

Mechanism and Therapeutic Reversal of Immune Suppression in Cancer

Clearwater Beach, Florida, January 25 to 28, 2007
Meeting Report: Cancer Research 2007
DOI: 10.1158/0008-5472.CAN-07-0897

Chemistry in Cancer Research: A Vital Partnership

Hosted by the Chemistry in Cancer Research Working Group (CICR) of the AACR, February 4 to 7, 2007, in San Diego, CA
Meeting Report: Cancer Research 2007
DOI: 10.1158/0008-5472.CAN-07-1619

Advances and Challenges in Aerodigestive Epithelial Cancer: Meeting Summary and Research Opportunities

Held in Charleston, South Carolina, February 6–9, 2007
Meeting Report: Cancer Research 2007
DOI: 10.1158//0008-5472.CAN-07-1733

Meeting Report: Translational Research at the Aging and Cancer Interface

San Diego, CA from February 20 to 23, 2007
Meeting Report: Cancer Research 2007
DOI: 10.1158/0008-5472.CAN-07-1236

Towards Clinical Application of Methylated DNA Sequences as Cancer Biomarkers: A Joint NCI's EDRN and NIST Workshop on Standards, Methods, Assays, Reagents and Tools

August 18-19, 2007 at National Institute of Standards and Technology, Gaithersburg, Maryland
Meeting Report: Cancer Research 2007
DOI: 10.1158/0008-5472.CAN-06-2888

Mitochondrial DNA and Cancer Epidemiology

The Analytic Epidemiology Research Branch of the National Cancer Institute (NCI) hosted this meeting in Bethesda, Maryland, on September 7 to 8, 2007
Meeting Report: Cancer Research 2007
DOI: 10.1158/0008-5472.CAN-06-4119

A Tribute to George F. Vande Woude, a Man of Character: 2007 Scientific Symposium Winning the War against Cancer: From Genomics to Bedside and Back 2007

September 10 to 12, 2007 at the Van Andel Research Institute in Grand Rapids, Michigan
Meeting Report: Cancer Research 2007
DOI: 10.1158/0008-5472.CAN-06-4304

The 3rd Pacific Rim Meeting on Breast and Prostate Cancer: Progress in Hormonal Carcinogenesis and the Enduring Influence of Ron Ross

Held in Queensland, Australia, from October 31 to November 4, 2007
Meeting Report: Cancer Research 2007
DOI: 10.1158/0008-5472.CAN-07-0280

Eleventh Prouts Neck Meeting on Prostate Cancer: Emerging Strategies in Prostate Cancer Therapy

Held November 2–5, 2007, in Prouts Neck, Maine
Meeting Report: Cancer Research 2007
DOI: 10.1158/0008-5472.CAN-07-1529

MicroRNA: Potential for Cancer Detection, Diagnosis, and Prognosis

Rockville, Maryland on November 28 and 29, 2007
Meeting Report: Cancer Research 2007
DOI: 10.1158/0008-5472.CAN-07-0563

 

Meetings Held in 2006

Proteasome Inhibitor Drugs on the Rise

AACR Special Conference, January 18-22, 2006, Orlando, Florida
Special Conference Report: Cancer Research 2006
DOI: 10.1158/0008-5472.CAN-06-2033

Cancer Stem Cells—Perspectives on Current Status and Future Directions: AACR Workshop on Cancer Stem Cells

AACR Workshop was held on February 2-4, 2006 in Lansdowne, Virginia
Special Workshop Report: Cancer Research 2006
DOI:  10.1158/0008-5472.CAN-06-3126

10th Biennial Helene Harris Memorial Trust Meeting

Meeting, April 2006, Washington, DC
Meeting Report: Cancer Research 2006
DOI: 10.1158/0008-5472.CAN-05-2093

I2 Imaging: Cancer Biology and the Tumor Microenvironment

(NCI)–sponsored think tank held in Alexandria, Virginia, on June 8 to 10, 2006
Meeting Report: Cancer Research 2006
DOI: 10.1158/0008-5472.CAN-06-3102

Cancer Chemoprevention and Cancer Preventive Vaccines—A Call to Action: Leaders of Diverse Stakeholder Groups Present Strategies for Overcoming Multiple Barriers to Meet an Urgent Need

Special Workshop June 12–13, 2006 in Bethesda, Maryland, at a "Cancer Prevention Research Summit," organized by C-Change with support from the AACR
Special Workshop Report: Cancer Research 2006
DOI: 10.1158/0008-5472.CAN-06-4122

Proceedings of the Fifth International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer

The Fifth International Conference, June 13-14, 2006, Cambridge, Massachusetts
Meeting Report: Clinical Cancer Research 2006
DOI: 10.1158/1078-0432.CCR-05-2268

Mouse Models of Human Cancers Consortium Workshop on Nervous System Tumors

NCI Workshop, June 17-18, 2006, St. Louis, Missouri
Workshop Report: Cancer Research 2006
DOI: 10.1158/0008-5472.CAN-05-3180

Eighteenth Annual Pezcoller Symposium: Tumor Microenvironment and Heterotypic Interactions

Symposium was held in Trento, Italy, from June 27 to 29, 2006
Symposium Report: Cancer Research 2006
DOI: 10.1158/0008-5472.CAN-06-3149

Innovations and Challenges in Melanoma

AACR Special Conference, July 15 to 16, 2006, in Cambridge, Massachusetts
Special Conference Report: Clinical Cancer Research 2006
DOI: 10.1158/CHANGE

Novel Agents in the Treatment of Lung Cancer: Advances in EGFR-Targeted Agents

The Third Conference, September 23 to 24, 2006, Cambridge, Massachusetts
Meeting Report: Clinical Cancer Research 2006
DOI: 10.1158/1078-0432.CCR-06-1005

Exploiting the Tumor Microenvironment for Therapeutics

2nd International Tumor Metabolism Summit, October 7 to 8, 2006, Genoa, Italy
Meeting Report: Cancer Research 2006
DOI: 10.1158/0008-5472.CAN-06-0069

The Markers and Tissue Resources for Melanoma

Meeting convened by the Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, Specialized Programs of Research Excellence at the Organ Systems Branch of the National Cancer Institute (NCI), and the Melanoma Research Foundation was held in Gaithersburg, Maryland, on October 27-28, 2006
Meeting Report: Cancer Research 2006
DOI: 10.1158/0008-5472.CAN-06-0921

Antiangiogenesis and Drug Delivery to Tumors: Bench to Bedside and Back

AACR Special Conference, November 9-12, 2006, Waltham, Massachusetts
Special Conference Report: Cancer Research 2006
DOI: 10.1158/0008-5472.CAN-05-4536

 

Fifth Annual AACR Frontiers in Cancer Prevention Research

Held in Boston, Massachusetts, in November 12-15, 2006
Meeting Report: Cancer Research 2006
DOI: 10.1158/0008-5472.CAN-07-3171

Pancreatic Cancer in Mice and Man: The Penn Workshop 2006

International Meeting, December 1-3, 2006, in Philadelphia, Pennsylvania
Meeting Report: Cancer Research 2006
DOI: 10.1158/0008-5472.CAN-05-3914

Meetings Held in 2005

Oncogenomics 2005: Dissecting Cancer through Genome Research

AACR Special Conference, February 2-5, 2005, San Diego, California
Meeting Report: Cancer Research 2005 65: 8587-8590

 

Meetings Held in 2004

The Role of Telomeres and Telomerase in Cancer

AACR Special Conference, November 3-7, 2004, San Francisco, California
Meeting Report: Cancer Research 2005 65: 3513-3517

Regulation of Cell Death in Oncogenesis

AACR Special Conference, January 26-30, 2005, Waikoloa, Hawaii
Meeting Report: Cancer Research 2005 65: 8069-8071

 

Meetings Held in 2003

SNPs, Haplotypes, and Cancer: Applications in Molecular Epidemiology

AACR Special Conference, September 13-17, 2003, Key Biscayne, Florida
Meeting Report: Cancer Epidemiology, Biomarkers & Prevention 2004 13: 681-687

 

Meetings Held in 2002

Apoptosis and Cancer

AACR Special Conference, February 13-17, 2002, Waikoloa, Hawaii
Meeting Report: Cancer Research 2003 63: 263-268

Proteases, Extracellular Matrix, and Cancer

AACR Special Conference, October 2002, Hilton Head, North Carolina
Meeting Report: Cancer Research 2003 63: 4750-4755

Frontiers in Cancer Prevention Research

AACR International Conference, October 14-18, 2002, Boston, Massachusetts
Meeting Report: Cancer Research 2003 63: 5649-5655

 

Reports of Other Scientific Meetings

Meetings Held in 2003

Oxygen Homeostasis/Hypoxia Meeting

Meeting, February 12, 2003, Washington, DC
Meeting Report: Cancer Research 2004 64: 3350-3356

Molecular Genetics of Multiple Myeloma

Roundtable Workshop, February 20-23, 2003, Paris, France
Meeting Report: Cancer Research 2004 64: 1546-1558

Frontiers of Mutagenesis and DNA Repair

Workshop, 2003, Ventura, California
Meeting Report: Cancer Research 2004 64: 3357-3360

Fifteenth Annual Pezcoller Symposium

Symposium, June 12-14, 2003, Rovereto, Italy
Meeting Report: Cancer Research 2004 64: 2929-2933

Stress Signaling in Cancer

International Union of Biochemistry and Molecular Biology Symposium, July 25-27, 2003, Quebec City, Canada
Meeting Report: Cancer Research 2004 64: 1893-1898

Novel Agents in the Treatment of Lung Cancer

1st International Conference, October 17-18, 2003, Cambridge, Massachusetts
Supplement to Clinical Cancer Research 2004 10: 4199S-4285S

• Conference Summary Statement 4199S-4204S
• Bronchioloalveolar Carcinoma: A Model for Investigating the Biology of Epidermal Growth Factor Receptor Inhibition 4205S-4209S
• Cytotoxic Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Review of Standard Treatment Paradigms 4210S-4214S
• Gene Expression as a Predictive Marker of Outcome in Stage IIB-IIIA-IIIB Non-Small Cell Lung Cancer After Induction Gemcitabine-Based Chemotherapy Followed By Resectional Surgery 4215S-4219S
• Curtailing the High Rate of Late-Stage Attrition of Investigational Therapeutics Against Unprecedented Targets in Patients with Lung and Other Malignancies 4220S-4226S
• The Biology of Epidermal Growth Factor Receptor in Lung Cancer 4227S-4232S
• The Role of Gefitinib in Lung Cancer Treatment 4233S-4237S
• The Role of Erlotinib (Tarceva, OSI 774) in the Treatment of Non-Small Cell Lung Cancer 4238S-4840S
• Cetuximab in Advanced Non-Small Cell Lung Cancer 4241S-4244S
• Oblimersen Sodium (Genasense bcl-2 Antisense Oligonucleotide): A Rational Therapeutic to Enhance Apoptosis in Therapy of Lung Cancer 4245S-4248S
• Molecularly Targeted Approaches to the Chemoprevention of Lung Cancer 4249S-4253S
• Farnesyl Transferase Inhibitors for Patients with Lung Cancer 4254S-4257S
• Anti-Vascular Endothelial Growth Factor Monoclonals in Non-Small Cell Lung Cancer 4258S-4262S
• The Potential Role of Proteasome Inhibitors in the Treatment of Lung Cancer 4263S-4265S
• Cyclooxygenase as a Target in Lung Cancer 4266S-4269S
• Preclinical and Clinical Development of the Cyclin-Dependent Kinase Inhibitor Flavopiridol 4270S-4275S
• Pemetrexed (ALIMTA), A Novel Multitargeted Antineoplastic Agent 4276S-4280S
• Clinical Trial Design Issues in the Era of Targeted Therapies 4281S-4282S

Validation of a Causal Relationship: Criteria to Establish Etiology

NCI Workshop, December 11-12, 2003, Washington, DC
Meeting Report: Cancer Research 2004 64: 5518-5524

Comparative Pathology of Nerve Sheath Tumors in Mouse Models and Humans

Workshop, 2003, Boston, Massachusetts
Meeting Report: Cancer Research 2004 64: 3718-3724

 

Meetings Held in 2002

American Society of Preventive Oncology

26th Annual Meeting, March 10, 2002, Bethesda, MD
Meeting Report: Cancer Epidemiology, Biomarkers & Prevention 2004 13: 1094-1098

Behavioral Oncology Interest Group Roundtable, March 10, 2002, Bethesda, MD
Meeting Report: Cancer Epidemiology, Biomarkers & Prevention 2004 13: 171-180